Fredun Pharmaceuticals (BOM:539730) EPS (Basic) : ₹39.90 (TTM As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Fredun Pharmaceuticals EPS (Basic)?

Fredun Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ₹11.29. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹39.90.

Fredun Pharmaceuticals's EPS (Diluted) for the three months ended in Dec. 2024 was ₹11.29. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹39.90.

Fredun Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2024 was ₹11.29. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 39.93.

During the past 12 months, Fredun Pharmaceuticals's average EPS without NRIGrowth Rate was 38.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 64.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 36.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 33.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Fredun Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 146.00% per year. The lowest was -8.50% per year. And the median was 53.15% per year.

Fredun Pharmaceuticals EPS (Basic) Historical Data

The historical data trend for Fredun Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fredun Pharmaceuticals EPS (Basic) Chart

Fredun Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

4.77

5.05

15.26

24.13

33.66

Fredun Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															9.05	10.77	8.79	9.05	11.29

Fredun Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Fredun Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(156.234	-	0)	/	4.642
	=	33.66

Fredun Pharmaceuticals's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(53.326	-	0)	/	4.723
	=	11.29

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹39.90

Fredun Pharmaceuticals (BOM:539730) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fredun Pharmaceuticals EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Fredun Pharmaceuticals's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Fredun Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fredun Pharmaceuticals Ltd (BOM:539730) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

Ganpatrao Kadam Marg, 11th Floor, Urmi Estate, Lower Parel (West), Mumbai, MH, IND, 400013

Website

http://www.fredungroup.com

Fredun Pharmaceuticals Ltd is an India based company engaged in the business of pharmaceuticals and healthcare. The company manufactures pharmaceutical formulations, nutraceuticals, herbal supplements, and dietary supplements. In addition, it also manufactures animal healthcare products through its group companies. It sells its products in India and also exports its formulations as branded generics to international countries.

Fredun Pharmaceuticals Headlines

No Headlines